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Edited by Takashi GojoboriAbstract Analysis of the exon–intron structures of 2208 human
genes has revealed that there is a statistically highly signiﬁcant
excess of phase 1 introns in the vicinity of the signal peptide
cleavage sites. It is suggested that amino acid sequences
surrounding signal peptide cleavage sites are signiﬁcantly
enriched in phase 1 proto-splice sites and this has favored
insertion of spliceosomal introns in these sites.
 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Keywords: Exon–intron structure; Intron insertion;
Proto-splice site; Signal peptide1. Introduction
One of the major enigmas of eukaryotic genome evolution is
the proliferation of spliceosomal introns of protein-coding
genes. Whereas genes of unicellular eukaryotes contain very
few introns, most genes of multicellular eukaryotes contain
several introns. In particular, in the vertebrate lineage protein-
coding genes usually have numerous introns and the size of
intronic DNA substantially exceeds the size of exonic DNA.
Although the mechanisms underlying the proliferation of
spliceosomal introns of eukaryotic protein-coding genes are
poorly understood, there is now general consensus that
spliceosomal introns arose only in the eukaryotic lineage
[1–3]. None of the completely sequenced prokaryotic genomes
shows any sign of ancient spliceosomal introns, supporting
the notion that spliceosomal introns were never present in
prokaryotes but arose soon after the origin of the ﬁrst eu-
karyotes. It is noteworthy in this respect that all eukary-
otic lineages that have been examined so far contain
spliceosomal introns and spliceosomal components necessary
for their removal [4–7].
There is now strong evidence that in all eukaryotic lin-
eages the loss and gain of spliceosomal introns is an ongoing
process [8–10]. To explore the evolutionary dynamics of
introns, Rogozin et al. [11] have recently compared the in-
tron positions of 684 orthologous gene sets from eight
complete genomes of animals, plants, fungi, and protists and
constructed parsimonious scenarios for the evolution of the
exon–intron structure of these genes. The inferred evolu-* Corresponding author. Fax: +361-4665-465.
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of these eukaryotes had numerous introns, most of these
ancestral introns have been diﬀerentially lost in fungi,
nematodes, arthropods and Plasmodium. On the other hand,
numerous novel introns have been inserted into vertebrate
and plant genes, whereas in other lineages, intron gain was
much less prominent.
Although the processes leading to intron gain are still not
fully understood, the most plausible, most widely accepted
hypothesis is that intron insertion may occur via a process
similar to group II intron retrotransposition [12–15]. Accord-
ing to this hypothesis, the spliceosomal components remain
transiently associated with a recently excised intron and then
attach at a potential splice site of a non-homologous pre-
mRNA, where they catalyze the reverse reaction. The modiﬁed
pre-mRNA is reverse transcribed, the resulting cDNA partic-
ipates in a recombination with its parent gene thereby inserting
a novel intron into the gene. An attractive feature of this
mechanism is that it ensures that the inserted sequence has the
full complement of intron signature sequences required for
eﬃcient splicing. Furthermore, this pathway would guide in-
tron insertion to sites – proto-splice sites – that possess the
appropriate exonic features that facilitate eﬃcient splicing
[16,17]. Selection thus favors insertion of perfect spliceosomal
introns into such proto-splice sites: the inserted intron will be
accepted only if it is eﬃciently spliced out. Insertion in a region
that does not conform to the proto-splice-site consensus will
not be tolerated.
The recent work by Coghlan and Wolfe [18] provides strong
evidence for insertion of novel introns in proto-splice sites.
These authors have compared the genomes of the nematodes
Caenorhabditis elegans and Caenorhabditis briggsae and iden-
tiﬁed >6000 introns that are unique to one or the other species.
Through phylogenetic analysis, they have identiﬁed 122 cases
where an intron content diﬀerence between C. elegans and
C. briggsae was caused by intron insertion rather than dele-
tion. Signiﬁcantly, novel introns were found to have a much
stronger exon splice site consensus sequence (AG/G) than the
general population of introns, suggesting that novel introns
tend to be inserted at AG#G, where # is the insertion site.
These ﬁndings support the conclusion of Qiu et al. [19] that
recently gained introns of eukaryotic protein families are
inserted into AG#G sites.
In the present work, we provide evidence that amino acid
sequences surrounding signal peptide cleavage sites are sig-
niﬁcantly enriched in phase 1 proto-splice sites and this has
favored insertion of spliceosomal introns in these sites.blished by Elsevier B.V. All rights reserved.
Table 1
Distribution of introns in the translated regions of human genes
encoding proteins that lack or possess N-terminal secretory signal
peptides
Proteins lacking
signal peptide
Proteins with
signal peptide
Number of protein sequences 1497 711
Total number of introns 11473 4978
Phase 0 intron 5444, 47.4% 1765, 35.5%
Phase 1 intron 3428, 29.9% 2336, 46.9%
Phase 2 intron 2601, 22.7% 877, 17.6%
Introns in the ﬁrst 100 residues 2483 1210
Phase 0 intron 1107, 44.6% 379, 31.3%
Phase 1 intron 840, 33.8% 604, 49.9%
Phase 2 intron 536, 21.6% 227, 18.8%
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Full-length human protein sequences were selected from the
Swiss-Prot 41.11 database, http://www.expasy.org/sprot [20],
identiﬁed by gene name and duplicates were removed. In the
resulting database, 1873 sequences with unique gene names
were found to possess an N-terminal signal peptide, 6325 se-
quences lacked a signal peptide. The boundaries of their signal
peptide domains were deﬁned using the annotations of the
Swiss-Prot database entries.
The human subset of the Exon-Intron Database EID132,
http://www.mcb.harvard.edu/gilbert/eid [21], was searched
with these sequences and the matching entries were compiled
together with information on the position and phase class of
their introns. The resulting databases contained 711 genes of
signal peptide containing proteins and 1497 genes of proteins
lacking a signal peptide (Table 1).
To compare the frequency distribution of phase 0, phase 1 and
phase 2 introns along the sequences of human proteins con-
taining or lacking signal peptides, the ﬁrst 100 residues of both
groups were analyzed. The distribution of introns located in the
N-terminal 100 residues of human proteins lacking a signal
peptide has shown a rather uniform pattern along the sequence
(Fig. 1A) for all three intron phase classes. The relative fre-
quency of phase 0 introns (44.6%), phase 1 introns (33.8%) and
phase 2 introns (21.6%) in this N-terminal region is quite similar
to that observed for the full-length proteins (phase 0 intron:Fig. 1. Frequency distribution of phase 0, phase 1 and phase 2 introns along t
genes. Left panel: genes of 1497 human proteins lacking N-terminal signal pe
secretory signal peptides. The top row in the right panel shows the length distr
introns coincides with the C-terminal boundary of signal peptide-domains.47.4%, phase 1 intron: 29.9%, phase 2 intron: 22.7%; cf. Table 1).
These observations are in harmony with the previous ﬁndings
that, in general, phase 0 introns are the most abundant (ap-
proximately 50%), followed by phase 1 introns (about 30%)with
phase 2 introns being the least abundant (about 20%) [22,23].
The distribution of introns located in the N-terminal 100
residues of human proteins possessing a signal peptide is
strikingly diﬀerent from that observed in the case of proteins
lacking a signal peptide (cf. Fig. 1A and B). First, phase 1
introns are signiﬁcantly more abundant (49.9%) than phase 0
introns (31.36%) or phase 2 introns (18.8%). Second, the dis-
tribution of introns along the sequence is far from uniform:he ﬁrst 100 amino acid residues of the translated regions of 2208 human
ptides. Right panel: genes of 711 human proteins possessing N-terminal
ibution of signal peptides. Note that in panel B a peak of excess phase 1
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sponding to the N-terminal 15–25 amino acids, whereas the
region corresponding to residues 1–15 is signiﬁcantly depleted
in phase 0 introns and phase 2 introns (Fig. 1B). It is very
likely that both types of deviations reﬂect the presence of the
signal peptides: phase 0 and phase 2 introns are depleted in the
N-terminal hydrophobic regions of the signal peptides,
whereas the phase 1 intron peak coincides with the signal
peptide cleavage sites (cf. top row of Fig. 1B).
The most plausible explanation for the inﬂuence of signal
peptide domains on intron phase distributions is that some
features of signal peptides favor intron insertion in phase 1 in
the vicinity of the cleavage site, whereas other features disfavor
insertion of introns in the N-terminal hydrophobic part.
As discussed in Section 1, introns are most likely to be
inserted into genes at so called ‘‘proto-splice sites’’: se-
quences similar to the conserved coding sequences that
usually ﬂank introns [16]. Recent statistical analysis of a
large number of exon–intron junction sequences has revealed
that the proto-splice site is practically restricted to AG/G
surrounding the intron, the information content being
highest for the positions adjacent to the introns [24]. In
translated regions, the base preferences of proto-splice sites
(AG/G) are also manifested in some amino acid preferences
at exon–intron junctions [23]. As a consequence, phase 2
introns most frequently split the arginine codon AGG,
whereas phase 1 introns most frequently split the four GGN
codons encoding glycine [23].
An analysis of the cleavage site matrices of eukaryotic signal
peptides indicates that glycine residues are signiﬁcantly
enriched in positions )1, )3, )4 and )5 [25] (http://
www.cbs.dtu.dk/services/SignalP/sp_matrices.html). It seems
thus likely that the peak of phase 1 introns in the vicinity of
signal peptide cleavage sites is a consequence of the abundance
of glycines in this region, which present phase 1 proto-splice
sites and this favors the insertion of introns in phase 1.
Conversely, the predominance of leucine in the hydrophobic
N-terminal part of eukaryotic signal peptides from positions
)13 to )6 [25] (http://www.cbs.dtu.dk/services/SignalP/
sp_matrices.html), may explain the fact that there are signiﬁ-
cantly fewer phase 0 and phase 2 introns in this region than
expected by chance (cf. Fig. 1B). Since none of the six codons
of leucine (CTN, TTR) satisfy the proto-splice-site consensus
sequence AG/G in either phase 0 or phase 2, the leucine-rich
region is a very poor target for insertion of perfect spliceoso-
mal introns in phase 0 or phase 2.
The fact that insertion of phase 1 introns at the boundary of
signal peptide domains has been facilitated by the abundance
of proto-splice sites in these regions has some important con-
sequences for gene prediction. In the majority of cases, the
signal peptide domains of secreted proteins or transmembrane
proteins are encoded by separate exons (cf. Table 1.) making
their detection one of the major problems of gene prediction
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